Circulation · 2004 · 159 citations · 18 references
Life SciencesImmunologyInfectious DiseasesInnate ImmunityMolecular VirologyVirologyAntiviral ImmunityAntiviral TherapyInnate Immune ResponseInterferon ResponsesViral InfectionsViral PathogenesisAntiviral Cytokine ResponsesAntiviral Innate SignalingAntiviral Interferon ResponsesCoxsackievirus InfectionsHost Immune Response ModulationInterferon Pathway GenesInterferon Response To Viral InfectionViral Myocarditis
BACKGROUND: Coxsackievirus-induced myocarditis can be a serious cause of heart failure. In the absence of a specific antiviral therapy, modulating the host immune response may be protective. Interferons (IFNs)-alpha and -beta perform a fundamental role in innate and adaptive antiviral responses, thereby presenting as candidate therapeutics for coxsackievirus infections. METHODS AND RESULTS: To examine the contribution of IFN-beta in protection from coxsackievirus B3 (CVB3) infection, mice lacking the IFN-beta gene were infected with 10(3) plaque-forming units of CVB3. In contrast to wild-type mice that exhibit an intact IFN-beta response, we observed increased susceptibility to infection (70% mortality), a downregulation of IFN-stimulated gene targets (2'-5' oligoadenylate synthetase, serine/threonine protein kinase, the GTPase Mx), and cardiomyocyte breakdown and disruption in the IFN-beta-/- mice. CONCLUSIONS: Viewed together, these results clearly demonstrate that IFN-beta is important in mediating protection against CVB3-induced myocarditis.
18
Advances in the Understanding of Myocarditis
Peter P. Liu, Jay W. Mason · Circulation · 2001 · 493 citations
Medicine, Cardiology, Pathology +9